[Direct answer]In the Beijing area, if subjects in clinical trials suffer harm, insurance usually covers the costs, but it's not an "unconditional full compensation". According to the "Quality Management Standards for Drug Clinical Trials" (effective from July 1, 2020), sponsors should purchase clinical trial insurance for subjects or provide reasonable compensation; according to the "Drug Administration Law of the People's Republic of China" (revised and implemented on December 1, 2019) and the "Civil Code" (effective from January 1, 2021), if subjects suffer personal harm due to the trial, they can claim compensation from the sponsors and medical institutions. Whether they can get compensation depends on whether there is a causal relationship between the harm and the trial measures, whether the obligation of informed consent and protection has been fulfilled, and whether it is a case of exemption from liability. It is recommended to fix the informed consent form, enrollment records, and medication and treatment records as soon as possible, and submit a written claim to the sponsor. For more details, please refer to the following link:Legal services for personal injury and medical disputes.

1. Problem background and typical scenarios

Clinical trials (especially Phase I to III trials of new drugs) may result in expected adverse reactions in subjects during the process of administering experimental drugs, invasive examinations, or control withdrawal. They may also lead to serious unanticipated harm, such as organ damage, infections, exacerbation of pre-existing diseases, or even death. Typical scenarios include: the experimental drug causing liver and kidney dysfunction; subjects in the control group being incorrectly assigned or failing to take standard treatment, resulting in disease progression; trauma caused by pre-enrollment screening; and subjects experiencing protocol-related accidental injuries during the trial. Many subjects mistakenly believe that "signing the informed consent means giving up the right to claim compensation", or that they must bear the harm themselves. In fact, the informed consent form does not exempt sponsors and institutions from their legal obligations to provide compensation and protection. In cases involving employment or occupational exposure, relevant provisions can be combined with the informed consent form to address potential liabilities.Labor arbitration and work-related injury compensation servicesComprehensively determine the responsible parties.

II. Key points of contention

Such disputes focus on three aspects. First, determination of causality: Whether the damage is directly caused by the experimental drug or the operation, or by the progress of the subject's own disease, concomitant medication, or random events, often requires professional medical appraisal and comparison with the protocol. Second, fulfillment of the obligation to inform and protect: Whether the sponsor and investigator have fully informed the subject of the risks, and whether they have monitored and dealt with adverse events according to the protocol, directly affect the determination of fault. Third, the connection between insurance claims and civil compensation: Whether the insurance covers the scope of exemption from liability and indemnity, and whether the insured can still claim against the sponsor for the insufficient part after the insurance pays. For cases involving multi-institutional cooperation, reference can be made to the relevant provisions.Business and contract dispute services for enterprisesClarify the responsibilities of all parties in the agreement.

III. Professional analysis by Hengluo Law Firm

Based on practical experience in handling medical damage and subject rights cases, the most common obstacles in clinical trial damage claims are "causality and evidence consolidation". Sponsors often claim that the damage is due to their own diseases or uncontrollable risks, while researchers may use the "they have been informed" defense to evade responsibility for monitoring failures. In accordance with the rules on fault and causality in the Tort Liability Chapter of the Civil Code and the requirements for sponsors to purchase insurance and handle adverse events set forth in the Quality Management Guidelines for Drug Clinical Trials, Hengluo Lawyers usually recommend the following: Retain all documents and communication records from the moment of enrollment, immediately seal the medical records and drug samples upon the occurrence of damage, apply for adverse event reporting records, and, if necessary, commission a medical damage appraisal. For insurance rejection cases, claimants can pursue both insurance claims and tort compensation simultaneously. For multi-center cross-regional cases, follow-up procedures can be initiated accordingly.Special services and other case-related servicesCoordinate the collection of evidence.

IV. Practical suggestions and legal basis

The legal basis mainly includes the "Quality Management Guidelines for Drug Clinical Trials" (implemented on July 1, 2020) regarding the requirements for sponsors to purchase insurance or provide compensation for subjects; the provisions on the protection of subjects' rights in the "Drug Administration Law of the People's Republic of China" (amended and implemented on December 1, 2019); Articles 116 (liability for fault) and 117 (scope of compensation for personal injury) of the "Civil Code" (implemented on January 1, 2021) and related provisions on medical damage liability; as well as the "Regulations on the Prevention and Handling of Medical Disputes" (implemented on October 1, 2018). Practical suggestions: Verify the content of insurance and informed consent before participating in the trial; seal the medical records and apply for adverse event records after damage occurs; first file a written claim against the sponsor and insurance company; if no agreement is reached, initiate litigation through both contractual and tort claims, paying attention to the three-year statute of limitations. For cases involving disability appraisal, relevant provisions can be referenced.Creditor-debtor relations and enforcement case servicesAdvance the execution of compensation payments.

5. Henglu Law Firm's Reminder

When participating in clinical trials, don't give up asserting your rights just because you've signed the consent form. First, secure full evidence of informed consent, enrollment, and treatment to determine whether the harm occurred during the trial-related processes. Second, distinguish between "predictable adverse reactions" and "trial-induced harm". For the former, focus on insurance and compensation; for the latter, consider tort compensation. Third, make full use of both insurance claims and civil claims. If the sponsor evades responsibility or the institution refuses to cooperate, it is recommended to consult a professional lawyer as soon as possible to avoid losing rights due to the modification of medical records or the expiration of the statute of limitations. For more ways to protect your rights, please refer to the relevant guidelines.The official website of Beijing Henglu Law Firm.

VI. Frequently Asked Questions

Q1: If something goes wrong during a clinical trial, can I be sure to receive insurance compensation?

It cannot be simply inferred that compensation is inevitable just because there is insurance. Whether the insurance will pay out depends on the coverage scope stipulated in the insurance policy, the exemption clauses, and the nature of the damage: if the damage belongs to an adverse event related to the trial and occurs within the insurance period, it is usually possible to apply for compensation according to the insurance policy; but if it belongs to a clear exemption (such as the subject's intentional actions, failure to follow medical instructions, or their own diseases), the insurance company may refuse to pay. In addition, insurance compensation does not replace the sponsor's statutory liability for compensation - when the damage is caused by the sponsor's or investigator's fault and exceeds the insurance coverage, the sponsor or investigator may still claim tort compensation for the difference. Therefore, whether the claim can be successful depends on whether the evidence can prove the link between the damage and the trial and the defects in the other party's performance of obligations, rather than just an insurance policy. It is recommended to review the insurance policy terms and the compensation commitments in the informed consent before making a claim, and if necessary, consult a lawyer to evaluate the two-track approach.

Q2: What evidence do I need to prepare to prove that the experiment caused damage?

The core is the three sets of evidence: "trial-related materials + damage facts + defects in obligations": 1. Enrollment and informed consent materials (protocol, insurance certificates, risk disclosure), proving that you were in a trial relationship and were informed of the risks; 2. Diagnosis and monitoring records (medication records, laboratory reports, imaging results, adverse event reporting forms, investigator follow-up records), proving the occurrence of damage and its temporal and causal relationship with the trial; 3. Communication and handling evidence (sponsor and institution's correspondence, complaint records), proving whether the other party handled the matter promptly; 4. Disability or death appraisal reports, quantifying the damage consequences. The organization of evidence should focus on "damage occurring during the trial period, non-existence of personal diseases, and the other party's faults in disclosure or monitoring". If the materials are controlled by the institution, you can apply to the court for their retrieval or evidence preservation.

Q3: How much will the attorney's fees and litigation costs be for a claim?

The litigation fees are calculated in accordance with the "Measures for the Payment of Litigation Costs" based on the amount of the litigation request (usually the total of medical expenses, disability compensation, loss of income, etc.), and are borne by the losing party. Lawyer's fees are charged on a per-case basis or as a percentage of the case value, depending on the complexity of the case, the need for appraisal, and the amount of the claim. The specific fees are subject to the terms of the engagement contract, and there is no uniform standard. Medical damages often require the appointment of a judicial appraiser, and the appraisal fees are charged separately but can be claimed from the responsible party. It is recommended to calculate the total amount of compensation that can be claimed before suing, and compare it with the lawyer's fees, appraisal fees, and litigation fees to assess the cost-benefit ratio. For parts that can be directly compensated by insurance, it is preferable to pursue insurance claims to reduce the litigation burden. Specific fees can be discussed with the law firm and included in the written engagement contract.

Q4: How long does it usually take from the occurrence of the damage to receiving the compensation?

The timeframes vary significantly depending on the legal path taken. For insurance claims, the case is typically concluded within weeks to months after all required materials are submitted. If the case proceeds to litigation, the first-instance ordinary procedure typically concludes within six months and the summary procedure within three months, though medical malpractice cases often take longer due to expert appraisals, with the overall process potentially lasting around a year. Appeals add several additional months. Disability appraisals themselves can take one to several months and are a common bottleneck. If the other party refuses to fulfill their obligations after the judgment takes effect, it is necessary to apply for enforcement. It is recommended to immediately initiate evidence preservation and insurance reporting after the damage occurs, advance appraisals and negotiations simultaneously, and, if necessary, apply for property preservation during litigation to shorten the actual period of compensation.

Q5: As a subject, what should I do first specifically?

Here are the four steps recommended: 1. Immediately report the damage to the sponsor and the research institution in writing, and request a record of adverse events. At the same time, make copies or take photos of the informed consent form, the enrollment notice, and all medical records. 2. Submit a claim to the insurance company and keep the acceptance receipt. Check whether the insurance policy covers the damage. 3. If the negotiation or claim process is blocked, hire a lawyer with experience in medical disputes to assess the causality and fault. If necessary, apply for a medical injury appraisal. 4. Within the three-year statute of limitations, claim compensation through two channels: the insurance contract and tort liability. Prioritize insurance compensation and seek additional compensation from the sponsor and the institution if necessary. Throughout the process, keep all communication records and never sign waivers or one-time compensation agreements without authorization.

The above content is based on the compilation of judicial practices in the Beijing area. The facts of individual cases and the jurisdiction of the court may affect the conclusions. Welcome to consult Henglu Law Firm for specific cases.

If you are facing similar problems, it is recommended that you consult a professional lawyer as soon as possible with the evidence materials, so as to avoid missing the statutory time limit. →Personal injury legal services·Beijing Hengluo Law Firm

Disclaimer: This article is compiled based on the current laws and regulations and publicly available adjudication rules, and is for general reference only. It does not constitute a formal legal opinion on specific cases. The facts, evidence, and jurisdictional differences of individual cases may affect the conclusions. In case of disputes, please consult a practicing lawyer in time.